Bausch Health Co. Inc. (BHC) Misses Q3 EPS by $1.26, provides guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q3 EPS of ($0.23), $1.26 worse than the analyst estimate of $1.03. Revenue for the quarter came in at $2.51 billion versus the consensus estimate of $2.42 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2024 revenue of $9.5-9.675 billion, versus the consensus of $9.489 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance